AAEM CASE-REPORT .29. PROLONGED PARALYSIS AFTER NEUROMUSCULAR BLOCKADE

被引:24
作者
GOOCH, JL [1 ]
机构
[1] UNIV UTAH,DEPT PHYS MED & REHABIL,SALT LAKE CITY,UT
关键词
NEUROMUSCULAR BLOCKADE; NONDEPOLARIZING NEUROMUSCULAR BLOCKING DRUG; PARALYSIS; CORTICOSTEROIDS; MYOPATHY;
D O I
10.1002/mus.880180903
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Nondepolarizing neuromuscular blocking agents (NMBA) are being used with increasing frequency in critically ill patients. Recently, many centers have described patients with prolonged muscle weakness after long-term use of these agents, either alone or in combination with other agents or disorders. Brief weakness lasting several hours to several days is probably the result of prolonged neuromuscular blockade, while more prolonged weakness lasting several weeks to months is, in all likelihood, caused by a myopathy. Patients with this myopathic disorder have flaccid paralysis with intact cognition and sensation. Electrodiagnostic findings include decreased M-wave amplitudes, positive waves and fibrillations, and rapid recruitment of small amplitude short duration, polyphasic motor unit potentials. Muscle biopsy findings include atrophy of type I and type II fibers, myofiber necrosis, and selective loss of thick myofilaments. The myopathy is believed to be related to the prolonged use of NMBA either alone or in combination with other disorders or medications, particularly corticosteroids. The weakness experienced by these patients leads to additional respiratory compromise, difficulty weaning from the ventilator, and prolonged hospitalization. (C) 1995 Judith L. Gooch, MD. Published by John Wiley and Sons, Inc.
引用
收藏
页码:937 / 942
页数:6
相关论文
共 34 条
[1]   PROLONGED PARALYSIS DUE TO NONDEPOLARIZING NEUROMUSCULAR BLOCKING-AGENTS AND CORTICOSTEROIDS [J].
BAROHN, RJ ;
JACKSON, CE ;
ROGERS, SJ ;
RIDINGS, LW ;
MCVEY, AL .
MUSCLE & NERVE, 1994, 17 (06) :647-654
[2]   PROLONGED MYASTHENIC SYNDROME AFTER ONE WEEK OF MUSCLE-RELAXANTS [J].
BENZING, G ;
IANNACCONE, ST ;
BOVE, KE ;
KEEBLER, PJ ;
SHOCKLEY, LL .
PEDIATRIC NEUROLOGY, 1990, 6 (03) :190-196
[3]   POLYNEUROPATHY IN CRITICALLY ILL PATIENTS [J].
BOLTON, CF ;
GILBERT, JJ ;
HAHN, AF ;
SIBBALD, WJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1984, 47 (11) :1223-1231
[4]   MYOPATHY WITH THICK FILAMENT (MYOSIN) LOSS FOLLOWING PROLONGED PARALYSIS WITH VECURONIUM DURING STEROID TREATMENT [J].
DANON, MJ ;
CARPENTER, S .
MUSCLE & NERVE, 1991, 14 (11) :1131-1139
[5]  
DECOUL AAW, 1980, CLIN NEUROL NEUROSUR, V87, P17
[6]   MYOPATHY IN SEVERE ASTHMA [J].
DOUGLASS, JA ;
TUXEN, DV ;
HORNE, M ;
SCHEINKESTEL, CD ;
WEINMANN, M ;
CZARNY, D ;
BOWES, G .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (02) :517-519
[7]   A POSSIBLE ROLE FOR GLUCOCORTICOIDS IN DENERVATION ATROPHY [J].
DUBOIS, DC ;
ALMON, RR .
MUSCLE & NERVE, 1981, 4 (05) :370-373
[8]  
GOOCH JL, 1993, ARCH PHYS MED REHAB, V74, P1007
[9]   PROLONGED PARALYSIS AFTER TREATMENT WITH NEUROMUSCULAR-JUNCTION BLOCKING-AGENTS [J].
GOOCH, JL ;
SUCHYTA, MR ;
BALBIERZ, JM ;
PETAJAN, JH ;
CLEMMER, TP .
CRITICAL CARE MEDICINE, 1991, 19 (09) :1125-1131
[10]   ACUTE MYOPATHY DURING TREATMENT OF STATUS-ASTHMATICUS WITH CORTICOSTEROIDS AND STEROIDAL MUSCLE-RELAXANTS [J].
GRIFFIN, D ;
FAIRMAN, N ;
COURSIN, D ;
RAWSTHORNE, L ;
GROSSMAN, JE .
CHEST, 1992, 102 (02) :510-514